Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

NCT01064921 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Stage III Squamous Cell Carcinoma of the Oropharynx
Stage IV Squamous Cell Carcinoma of the Oropharynx

Interventions

DRUG: vorinostat
DRUG: cisplatin
RADIATION: radiation therapy
PROCEDURE: Correlative Studies

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]